48 related articles for article (PubMed ID: 10875063)
1. CYP2D6 genotypes in revolving door patients with bipolar disorders: A case series.
Seripa D; Lozupone M; Miscio G; Stella E; La Montagna M; Gravina C; Urbano M; di Mauro L; Daniele A; Greco A; Logroscino G; Panza F; Bellomo A
Medicine (Baltimore); 2018 Sep; 97(37):e11998. PubMed ID: 30212929
[TBL] [Abstract][Full Text] [Related]
2. CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials.
Peñas-Lledó EM; Llerena A
Br J Clin Pharmacol; 2014 Apr; 77(4):673-83. PubMed ID: 24033670
[TBL] [Abstract][Full Text] [Related]
3. [Add-on value of plasma assays during prescription of antipsychotics].
Constant É
Rev Med Liege; 2024 Jan; 79(1):41-47. PubMed ID: 38223969
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiological implications of neurovascular P450 in brain disorders.
Ghosh C; Hossain M; Solanki J; Dadas A; Marchi N; Janigro D
Drug Discov Today; 2016 Oct; 21(10):1609-1619. PubMed ID: 27312874
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.
Jaquenoud Sirot E; van der Velden JW; Rentsch K; Eap CB; Baumann P
Drug Saf; 2006; 29(9):735-68. PubMed ID: 16944962
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant drugs in the elderly--role of the cytochrome P450 2D6.
Vandel P
World J Biol Psychiatry; 2003 Apr; 4(2):74-80. PubMed ID: 12692778
[TBL] [Abstract][Full Text] [Related]
7. Drug extrapyramidal side-effects or not: is there a dextromethorphan phenotype difference?
Vandel P; Haffen E; Vandel S; Bonin B; Sechter D; Bizouard P; Dalery J
Therapie; 2000; 55(3):349-53. PubMed ID: 10967711
[TBL] [Abstract][Full Text] [Related]
8. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
Plesnicar BK; Zalar B; Breskvar K; Dolzan V
J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
[TBL] [Abstract][Full Text] [Related]
9. CYP2D6 genotypes in Puerto Rican psychiatry patients with intolerance of antidepressants and antipsychotics.
Gonzalez-Tejera GM; Corey S
Bol Asoc Med P R; 2009; 101(1):7-12. PubMed ID: 19954080
[TBL] [Abstract][Full Text] [Related]
10. Cyp2d6*3, *4, *5 and *6 polymorphisms and antipsychotic-induced extrapyramidal side-effects in patients receiving antipsychotic therapy.
Crescenti A; Mas S; Gassó P; Parellada E; Bernardo M; Lafuente A
Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):807-11. PubMed ID: 18346175
[TBL] [Abstract][Full Text] [Related]
11. CYP2D6 genotype predicts antipsychotic side effects in schizophrenia inpatients: a retrospective matched case-control study.
Kobylecki CJ; Jakobsen KD; Hansen T; Jakobsen IV; Rasmussen HB; Werge T
Neuropsychobiology; 2009; 59(4):222-6. PubMed ID: 19521114
[TBL] [Abstract][Full Text] [Related]
12. [Extrapyramidal side effects of neuroleptic and antidepressant treatment: assessment of potential risk factors through CYP2D6 genetic polymorphism].
Reggiani K; Vandel P; Haffen E; Sechter D; Bizouard P; Vandel S
Encephale; 2000; 26(1):62-7. PubMed ID: 10875063
[TBL] [Abstract][Full Text] [Related]
13. [Assessment of CYP2D6 activity as a form of optimizing antidepressant therapy].
Szewczuk-Bogusławska M; Grzesiak M; Beszłej JA; Kiejna A
Psychiatr Pol; 2004; 38(6):1093-104. PubMed ID: 15779673
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
